Skip to main content
. 2021 Mar 30;3(2):fcab056. doi: 10.1093/braincomms/fcab056

Table 4.

Overview of available metadata from interim analysis patient cohort

Metadata Cancer Non-cancer
Headache Yes 34 102
No 32 209
NA 3 5
Headache duration <1 month 10 49
<6 months 14 31
+6 months 8 115
NA 37 121
Headache worse in morning Yes 9 61
No 18 146
NA 42 109
Headache with nausea Yes 9 76
No 17 133
NA 43 107
Memory change Yes 13 124
No 47 185
NA 9 7
Personality change Yes 11 80
No 50 230
NA 8 6
Verbal fluency 15+ 26 47
<15 16 91
NA 27 178
Steroids Yes 35 50
No 4 105
NA 30 161
Anti-epileptic drugs Yes 20 17
No 49 299
Statins Yes 17 60
No 52 256
Anti-hypertensives Yes 18 93
No 51 223
Anti-thrombotics Yes 8 45
No 61 271
NSAIDs Yes 6 53
No 63 263
BMI S. underweight 2 5
Underweight 3 32
Normal 37 145
Overweight 18 91
Obese 6 19
S. obese 0 2
NA 3 22

Where data were unavailable or not recorded, ‘NA’ (not available) was noted.

BMI, body mass index; NSAID, non-steroidal anti-inflammatory drugs.